Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate.

NCT00239603 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2007-04-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of the OV-Watch to predict ovulation while women are taking clomiphene citrate.

Conditions

Interventions

DEVICE

OV-Watch

Sponsors & Collaborators

  • HealthWatchSystems, Inc.

    collaborator INDUSTRY
  • Emory University

    lead OTHER

Principal Investigators

  • Celia E Dominguez, MD · Emory Reproductive Center

Eligibility

Min Age
21 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-10-31
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00239603 on ClinicalTrials.gov